Table 2 Univariate predictors of ICU survival*
Characteristics | Non survivors n = 17 (19) | Survivors n = 74 (81) | p |
|---|---|---|---|
Characteristics at ICU admission | |||
Age (in years) | 40 ± 9 | 43 ± 10 | 0.13 |
Sex (M/F) | 7/10 | 23/51 | 0.57 |
Glasgow score | 8 ± 5 | 13 ± 4 | 0.0003 |
HIV infection | |||
Initial HIV diagnosis | 7 (37) | 10 (14) | 0.015 |
Stage C | 13 (76) | 56 (76) | 0.99 |
CD4 count at admission (cells/mm3) | 120 ± 98 | 206 ± 209 | 0.38 |
AIDS related diagnosis at ICU admission | 11 (65) | 35 (47) | 0.28 |
Care in ICU | |||
Mechanical ventilation | 17 (100) | 28 (38) | <0.0001 |
Duration of ventilation (days) | 12 ± 13 | 4 ± 9 | <0.0001 |
Vasoactive drugs | 5 (29) | 8 (11) | 0.06 |
Duration of vasoactive drugs use (days) | 2.5 ± 2.7 | 0.7 ± 1.7 | <0.0001 |
Use of HAART | |||
HAART at ICU admission | 6 (38) | 46 (62) | 0.09 |
§ immunovirological success at ICU admission | 2 (12) | 19 (26) | 0.34 |
HAART during ICU stay | 5 (29) | 27 (36) | 0.78 |